Pharmaceutical Technology1 天
Deucravacitinib by Bristol-Myers Squibb for Rosacea: Likelihood of Approval
Deucravacitinib is under clinical development by Bristol-Myers Squibb and currently in Phase II for Rosacea. According to GlobalData, Phase II drugs for Rosacea have a 38% phase transition success ...
Pharmaceutical Technology1 天
Fostamatinib disodium by Rigel Pharmaceuticals for Coronavirus Disease 2019 (COVID-19 ...
Fostamatinib disodium is under clinical development by Rigel Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia.
Health on MSN3 天
Is Laser Hair Removal a Good Option for Hidradenitis Suppurativa (HS)?
Medically reviewed by Marisa Garshick, MD Laser hair removal is a safe and effective option for treating hidradenitis ...
NBC Los Angeles4 天
Why does my armpit hurt? 9 common causes, according to doctors
Treatment involves avoiding the irritant and using creams or ointments to repair ... Shaving or waxing are common ways people ...